Macalampad, Retchielle B.
HRN: 29-07-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2026
MUPIROCIN 2%, 15G (TUBE)
06/15/2026
06/22/2026
TOPICAL
15g
BID
Post USO
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: